MedPath
FDA Approval

Azithromycin Dihydrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 9, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Azithromycin(500 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

RPK Pharmaceuticals, Inc.

RPK Pharmaceuticals, Inc.

147096275

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Azithromycin Dihydrate

Product Details

NDC Product Code
53002-2221
Application Number
ANDA065509
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 28, 2017
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
HYDROXYPROPYL CELLULOSE (1200000 MW)Inactive
Code: RFW2ET671PClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: 5FD1131I7SClass: ACTIMQuantity: 500 mg in 1 1
TRIACETINInactive
Code: XHX3C3X673Class: IACT
© Copyright 2025. All Rights Reserved by MedPath